• +1-646-491-9876
    • +91-20-67278686

    Search

    Cholera - Pipeline Review, H1 2017

    Cholera - Pipeline Review, H1 2017

    • Report Code ID: RW0001689385
    • Category Healthcare
    • No. of Pages 42
    • Publication Month Feb-17
    • Publisher Name Global Markets Direct
    Report Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Cholera - Pipeline Review, H1 2017, provides an overview of the Cholera (Infectious Disease) pipeline landscape.

    Cholera is an acute infectious disease caused by a bacterium, Vibrio cholera, which results in a painless, watery diarrhea in humans. Symptoms of cholera can begin as soon as a few hours or as long as five days after infection. Often symptoms are mild. But sometimes they are very serious. Signs and symptoms of Cholera include rapid heart rate, loss of skin elasticity, low blood pressure, thirst, muscle cramps. If not treated, this can lead to shock and death in a matter of hours.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Cholera - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Cholera (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Cholera (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cholera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 2, 1 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 5 and 2 molecules, respectively.

    Cholera (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Report Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Cholera (Infectious Disease).
    - The pipeline guide reviews pipeline therapeutics for Cholera (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Cholera (Infectious Disease) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Cholera (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Cholera (Infectious Disease)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Cholera (Infectious Disease).
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Cholera (Infectious Disease) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    List of Tables
    List of Figures
    Introduction
    Publisher Report Coverage
    Cholera - Overview
    Cholera - Therapeutics Development
    Pipeline Overview
    Pipeline by Companies
    Pipeline by Universities/Institutes
    Products under Development by Companies
    Products under Development by Universities/Institutes
    Cholera - Therapeutics Assessment
    Assessment by Target
    Assessment by Mechanism of Action
    Assessment by Route of Administration
    Assessment by Molecule Type
    Cholera - Companies Involved in Therapeutics Development
    Akthelia Pharmaceuticals Ltd
    Beijing Minhai Biotechnology Co Ltd
    MSD Wellcome Trust Hilleman Laboratories Pvt Ltd
    Napo Pharmaceuticals Inc
    Cholera - Drug Profiles
    AKT-10082 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    cholera (trivalent) vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    cholera (whole cell) vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    cholera [strain O1/El/Tor/Ogawa] vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    cholera vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Cholvax - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    crofelemer DR - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    gram-negative bacterial infections vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    IMSUTMR-1501 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Peptide for Cholera and Guillain-Barre Syndrome - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecules for Bacterial Infections - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecules to Inhibit Sialic Acid Permease for Gram Negative Bacterial Infections - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Synthetic Peptides to Disrupt Cell Membrane for Bacterial and Fungal Infections - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Cholera - Dormant Projects
    Cholera - Discontinued Products
    Cholera - Product Development Milestones
    Featured News & Press Releases
    Apr 27, 2016: Hilleman Laboratories Provides Phase I/II Update on Cholera Vaccine
    Feb 03, 2015: Napo Files Brief on Appeal In Dispute With Salix
    Appendix
    Methodology
    Coverage
    Secondary Research
    Primary Research
    Expert Panel Validation
    Contact Us
    Disclaimer

    List of Tables

    Number of Products under Development for Cholera, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Cholera - Pipeline by Akthelia Pharmaceuticals Ltd, H1 2017
    Cholera - Pipeline by Beijing Minhai Biotechnology Co Ltd, H1 2017
    Cholera - Pipeline by MSD Wellcome Trust Hilleman Laboratories Pvt Ltd, H1 2017
    Cholera - Pipeline by Napo Pharmaceuticals Inc, H1 2017
    Cholera - Dormant Projects, H1 2017
    Cholera - Discontinued Products, H1 2017

    List of Figures

    Number of Products under Development for Cholera, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products by Targets, H1 2017
    Number of Products by Stage and Targets, H1 2017
    Number of Products by Mechanism of Actions, H1 2017
    Number of Products by Stage and Mechanism of Actions, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    Akthelia Pharmaceuticals Ltd
    Beijing Minhai Biotechnology Co Ltd
    MSD Wellcome Trust Hilleman Laboratories Pvt Ltd
    Napo Pharmaceuticals Inc

    Request for Sample

    Report Url https://www.reportsweb.com//cholera-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url https://www.reportsweb.com//cholera-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url https://www.reportsweb.com//cholera-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments